laitimes

Xinwei Medical (06609) increased the capital of three subsidiaries including Weiqi Medical by a total of 185 million yuan and increased investment in research and development of electrophysiology, lung intervention and computer-assisted technologies

author:Zhitong Finance

Zhitong Finance APP learned that Xinwei Medical (06609) announced that the company has recently completed the increase of investment in Shanghai Weiqi Medical Technology Co., Ltd. (Weiqi Medical), Shanghai Weilang Medical Technology Co., Ltd. (Weilang Medical) and Shanghai Shenji Medical Technology Co., Ltd. (Shenji Medical). After the completion of the capital contribution increase, the registered capital of Weiqi Medical will increase from RMB5 million to RMB70 million, and the registered capital of Weilang Medical and Shenji Medical will increase from RMB10 million to RMB70 million, and each of them will remain wholly owned subsidiaries of the Company.

Leveraging the Group's strengths in the field of neurointerventional devices and the unmet needs of the Chinese market, Weiqi Medical, Weilang Medical and Shenji Medical focus on medical device research and development in the fields of electrophysiology, lung intervention and calculator-assisted technology respectively.